
SK Bioscience Wins Patent Infringement Lawsuit Against Pfizer's Pneumococcal Vaccine
SK Bioscience wins patent lawsuit against Pfizer, paving way for pneumococcal vaccine sales and potentially reshaping global vaccine market dynamics
Yonhap Infomax
Hoban Group Acquires Less Than 3% Stake in LS - 'Purely for Investment Purposes'
Hoban Group acquires less than 3% stake in LS, citing investment in power industry growth, amid ongoing patent lawsuit between subsidiaries
Yonhap Infomax
LS Cable & System and Apple Patent Lawsuit - Heading Towards Settlement? Alternative Dispute Resolution Process Initiated
LS Cable & System and Apple initiate Alternative Dispute Resolution process for patent lawsuit, signaling potential settlement in wireless charging technology dispute
Yonhap InfomaxA Texas jury awards Netlist $118M in damages from Samsung after ruling that Samsung made and sold DRAM products infringing on Netlist’s patents. Major win in the tech patent battle! ⚖️💥
#Netlist #Samsung #PatentLawsuit #DRAM #TechNews #LegalVictory #IntellectualPropertyPalworld developer Pocketpair reveals Nintendo & Pokémon Company are seeking ~$65K in damages over alleged patent infringements. 🎮💥 The lawsuit cites three patents in question. 🧑⚖️
#Palworld #Nintendo #Pokémon #PatentLawsuit #GamingNews #LegalDrama #GameDev #IntellectualProperty #TechNews#Google faces a $7 billion patent infringement lawsuit in #Boston. Singular Computing alleges Google copied its #technology for #AI features in Search, Gmail, and Translate. Google denies wrongdoing.
https://www.slashinsider.com/google-faces-7bn-patent-infringement-trial/
#singularcomputing #technews #patentlawsuit #NewsUpdate

Google Faces $7 Billion Patent Infringement Trial Over AI Technology
Alphabet's Google is on trial in Boston over a $7 billion patent infringement claim by Singular Computing. The Massachusetts-based company alleges Google copied its AI technology for services like Search and Gmail. Google denies the accusations, citing independent development, and anticipates a two-to-three-week trial.
Slash Insider